Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)

18F-DCFPyL PET/CT Imaging in Patients with Biochemical Recurrence Prostate Cancer after Primary Local Therapy

Esther Mena, Maria Liza Lindenberg, Ismael Baris Turkbey, Joanna H. Shih, Stephanie Anne Harmon, Ilhan Lim, Frank I Lin, Stephen Adler, Philip Eclarinal, Yolanda McKinney, Deborah Citrin, William Dahut, Bradford Wood, Venkatesh Krishnasamy, Richard Chang, Elliot Levy, Maria Merino, Peter Pinto, Janet F. Eary and Peter L. Choyke
Journal of Nuclear Medicine November 2019, jnumed.119.234799; DOI: https://doi.org/10.2967/jnumed.119.234799
Esther Mena
1 Molecular Imaging Program. National Cancer Institute. NIH, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Liza Lindenberg
1 Molecular Imaging Program. National Cancer Institute. NIH, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ismael Baris Turkbey
1 Molecular Imaging Program. National Cancer Institute. NIH, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanna H. Shih
2 Division of Cancer Treatment and Diagnosis: Biometric Research Program. National Cancer Institute. NIH.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie Anne Harmon
3 Research Clinical Research Directorate, Frederick National Laboratory for Cancer Research Sponsored by National Cancer Institute. NIH;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ilhan Lim
1 Molecular Imaging Program. National Cancer Institute. NIH, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank I Lin
1 Molecular Imaging Program. National Cancer Institute. NIH, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Adler
4 Clinical Research Directorate, Frederick National Laboratory for Cancer Research Sponsored by National Cancer Institute. NIH;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Eclarinal
1 Molecular Imaging Program. National Cancer Institute. NIH, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yolanda McKinney
1 Molecular Imaging Program. National Cancer Institute. NIH, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah Citrin
5 Radiation Oncology Branch, CCR. NCI, NIH.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Dahut
6 Genitourinary Malignancies, NCI, NIH.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradford Wood
7 Center of Interventional Oncology. NCI, NIH.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Venkatesh Krishnasamy
7 Center of Interventional Oncology. NCI, NIH.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Chang
7 Center of Interventional Oncology. NCI, NIH.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elliot Levy
7 Center of Interventional Oncology. NCI, NIH.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Merino
8 Laboratory of Pathology, NCI, NIH;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Pinto
9 Urologic Oncology, NCI, NIH.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet F. Eary
10 Cancer Imaging Program, NCI, NIH.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter L. Choyke
1 Molecular Imaging Program. National Cancer Institute. NIH, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.119.234799
DOI 
https://doi.org/10.2967/jnumed.119.234799
PubMed 
31676732

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 1, 2019.

Article Versions

  • You are currently viewing a previous version of this article (November 1, 2019 - 13:36).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2019 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Esther Mena1,
  2. Maria Liza Lindenberg1,
  3. Ismael Baris Turkbey1,
  4. Joanna H. Shih2,
  5. Stephanie Anne Harmon3,
  6. Ilhan Lim1,
  7. Frank I Lin1,
  8. Stephen Adler4,
  9. Philip Eclarinal1,
  10. Yolanda McKinney1,
  11. Deborah Citrin5,
  12. William Dahut6,
  13. Bradford Wood7,
  14. Venkatesh Krishnasamy7,
  15. Richard Chang7,
  16. Elliot Levy7,
  17. Maria Merino8,
  18. Peter Pinto9,
  19. Janet F. Eary10 and
  20. Peter L. Choyke1
  1. 1 Molecular Imaging Program. National Cancer Institute. NIH, United States;
  2. 2 Division of Cancer Treatment and Diagnosis: Biometric Research Program. National Cancer Institute. NIH.;
  3. 3 Research Clinical Research Directorate, Frederick National Laboratory for Cancer Research Sponsored by National Cancer Institute. NIH;
  4. 4 Clinical Research Directorate, Frederick National Laboratory for Cancer Research Sponsored by National Cancer Institute. NIH;
  5. 5 Radiation Oncology Branch, CCR. NCI, NIH.;
  6. 6 Genitourinary Malignancies, NCI, NIH.;
  7. 7 Center of Interventional Oncology. NCI, NIH.;
  8. 8 Laboratory of Pathology, NCI, NIH;
  9. 9 Urologic Oncology, NCI, NIH.;
  10. 10 Cancer Imaging Program, NCI, NIH.
  1. For correspondence or reprints contact: Esther Mena, Molecular Imaging Program. National Cancer Institute. NIH, 9000 Rockville Pike, Blg 10, B3B402, Besthesda, MD 21217, United States. E-mail: esther.menagonzalez@nih.gov

Statistics from Altmetric.com

Cited By...

  • 43 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
    Michael J. Morris, Steven P. Rowe, Michael A. Gorin, Lawrence Saperstein, Frédéric Pouliot, David Josephson, Jeffrey Y.C. Wong, Austin R. Pantel, Steve Y. Cho, Kenneth L. Gage, Morand Piert, Andrei Iagaru, Janet H. Pollard, Vivien Wong, Jessica Jensen, Tess Lin, Nancy Stambler, Peter R. Carroll, Barry A. Siegel
    Clinical Cancer Research 2021 27 13
  • Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling
    Lauren Brady, Michelle Kriner, Ilsa Coleman, Colm Morrissey, Martine Roudier, Lawrence D. True, Roman Gulati, Stephen R. Plymate, Zoey Zhou, Brian Birditt, Rhonda Meredith, Gary Geiss, Margaret Hoang, Joseph Beechem, Peter S. Nelson
    Nature Communications 2021 12 1
  • Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions
    Nguyễn Thị Thanh Nhàn, Tohru Yamada, Kaori H. Yamada
    International Journal of Molecular Sciences 2023 24 16
  • The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
    Rang Wang, Guohua Shen, Mingxing Huang, Rong Tian
    Frontiers in Oncology 2021 11
  • Matched-Pair Comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non–Tumor-Related Uptake and Tumor Positivity
    Markus Kroenke, Lilit Mirzoyan, Thomas Horn, Jan C. Peeken, Alexander Wurzer, Hans-Jürgen Wester, Marcus Makowski, Wolfgang A. Weber, Matthias Eiber, Isabel Rauscher
    Journal of Nuclear Medicine 2021 62 8
  • Piflufolastat F 18: Diagnostic First Approval
    Susan J. Keam
    Molecular Diagnosis & Therapy 2021 25 5
  • PSMA Theranostics: Science and Practice
    Kgomotso Mokoala, Ismaheel Lawal, Thabo Lengana, Mankgopo Kgatle, Frederik L. Giesel, Mariza Vorster, Mike Sathekge
    Cancers 2021 13 15
  • 18F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation
    Gary A. Ulaner, Beth Thomsen, Jeffrey Bassett, Robert Torrey, Craig Cox, Kevin Lin, Trushar Patel, Tust Techasith, Audrey Mauguen, Steven P. Rowe, Liza Lindenberg, Esther Mena, Peter Choyke, Jeffrey Yoshida
    Radiology 2022 305 2
  • Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting
    Andrea K. Miyahira, Kenneth J. Pienta, John W. Babich, Neil H. Bander, Jeremie Calais, Peter Choyke, Michael S. Hofman, Steven M. Larson, Frank I. Lin, Michael J. Morris, Martin G. Pomper, Shahneen Sandhu, Howard I. Scher, Scott T. Tagawa, Scott Williams, Howard R. Soule
    The Prostate 2020 80 15
  • 18F-DCFPyL PET/CT for primary staging in 160 high-risk prostate cancer patients; metastasis detection rate, influence on clinical management and preliminary results of treatment efficacy
    M. Wondergem, F. M. van der Zant, W. A. M. Broos, T. A. Roeleveld, R. Donker, D. ten Oever, R. W. F. Geenen, R. J. J. Knol
    European Journal of Nuclear Medicine and Molecular Imaging 2021 48 2

Article usage

Article usage: November 2019 to April 2025

AbstractFullPdf
Nov 2019694094
Dec 2019129019
Jan 2020123026
Feb 2020129012
Mar 2020161023
Apr 2020105019
May 202068046
Jun 20208531377
Jul 20202371462
Aug 20201812165
Sep 20201571836
Oct 20201154234
Nov 2020702236
Dec 2020683936
Jan 2021373125
Feb 2021415243
Mar 2021384335
Apr 2021353521
May 2021376127
Jun 20212510633
Jul 2021216536
Aug 2021175937
Sep 2021176628
Oct 2021206451
Nov 2021276057
Dec 2021246231
Jan 2022377347
Feb 2022235031
Mar 2022217342
Apr 2022305743
May 2022194323
Jun 2022114730
Jul 202285135
Aug 2022144120
Sep 2022154225
Oct 2022103023
Nov 202272311
Dec 2022142517
Jan 2023153317
Feb 202394326
Mar 2023103920
Apr 2023161224
May 2023122921
Jun 202382510
Jul 2023112013
Aug 2023171618
Sep 2023132112
Oct 2023104614
Nov 202354216
Dec 2023131129
Jan 2024304016
Feb 2024143014
Mar 202441944
Apr 202457219
May 202426417
Jun 202493821
Jul 202474433
Aug 202484921
Sep 202425219
Oct 2024103219
Nov 202454216
Dec 202444810
Jan 202537217
Feb 20251012228
Mar 2025158024
Apr 20251111249
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-DCFPyL PET/CT Imaging in Patients with Biochemical Recurrence Prostate Cancer after Primary Local Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-DCFPyL PET/CT Imaging in Patients with Biochemical Recurrence Prostate Cancer after Primary Local Therapy
Esther Mena, Maria Liza Lindenberg, Ismael Baris Turkbey, Joanna H. Shih, Stephanie Anne Harmon, Ilhan Lim, Frank I Lin, Stephen Adler, Philip Eclarinal, Yolanda McKinney, Deborah Citrin, William Dahut, Bradford Wood, Venkatesh Krishnasamy, Richard Chang, Elliot Levy, Maria Merino, Peter Pinto, Janet F. Eary, Peter L. Choyke
Journal of Nuclear Medicine Nov 2019, jnumed.119.234799; DOI: 10.2967/jnumed.119.234799

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-DCFPyL PET/CT Imaging in Patients with Biochemical Recurrence Prostate Cancer after Primary Local Therapy
Esther Mena, Maria Liza Lindenberg, Ismael Baris Turkbey, Joanna H. Shih, Stephanie Anne Harmon, Ilhan Lim, Frank I Lin, Stephen Adler, Philip Eclarinal, Yolanda McKinney, Deborah Citrin, William Dahut, Bradford Wood, Venkatesh Krishnasamy, Richard Chang, Elliot Levy, Maria Merino, Peter Pinto, Janet F. Eary, Peter L. Choyke
Journal of Nuclear Medicine Nov 2019, jnumed.119.234799; DOI: 10.2967/jnumed.119.234799
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Changes in Management After 18F-DCFPyL PSMA PET in Patients Undergoing Postprostatectomy Radiotherapy, with Early Biochemical Response Outcomes
  • 18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study
  • Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy
  • 18F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval
  • Matched-Pair Comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non-Tumor-Related Uptake and Tumor Positivity
  • Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
  • Positive Predictive Value and Correct Detection Rate of 18F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard
  • Google Scholar

Similar Articles

Keywords

  • Oncology: GU
  • PET/CT
  • BCR
  • PET
  • PSMA
  • prostate cancer
SNMMI

© 2025 SNMMI

Powered by HighWire